Clementino Fraga Filho University Hospital
Rio de Janeiro, Brazil
NCT Number: NCT01173328
Pursed-lip breathing (PLB) has been advocated to reduce respiratory rate and improve oxygen saturation in patients with chronic obstructive pulmonary disease (COPD) at rest. Although PLB is a strategy that potentially reduces expiratory flow limitation, there are only few studies addressing its effects on exercise.
This study aimed to assess the ability of PLB to change the breathing pattern, degree of dynamic hyperinflation (DH) and arterial oxygenation in COPD patients during exercise. Exercise tolerance was evaluated by endurance time and respiratory mechanics was evaluated by forced oscillation technique.
Looking for future studies?
Notify Me40 year and older
All sexes
Interventional
Not applicable
Rio de Janeiro, Brazil
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Pursed-lip breathing involves a nasal inspiration followed by expiratory blowing against partially closed lips, avoiding forceful exhalation.
Time frame: within the first 01 hour
Time frame: within the first 01 hour
Time frame: within the first 01 hour
Time frame: within the first 01 hour
Time frame: within the first 01 hour
Looking for future studies?
Notify MeUniversidade Federal do Rio de Janeiro
Other
Effects of Pursed-lip Breathing on Exercise Tolerance and Dynamic Hyperinflation in Chronic Obstructive Pulmonary Disease
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07831629
Chronic Disease, Chronic Obstructive Pulmonary Disease
João Pessoa, Brazil
View Trial DetailsNCT06208306
Chronic Disease, Chronic Obstructive Pulmonary Disease
Chandler, Arizona, United States
View Trial DetailsNCT05001009
Brain Diseases, Cancer
Palo Alto, California, United States
View Trial DetailsNCT07016412
Chronic Disease, Chronic Obstructive Pulmonary Disease
Dothan, Alabama, United States
View Trial Details